Life Sciences
Cell and Gene Therapy: Unified Digital Solutions for R&D
In this session of Learning Labs, sponsored by Benchling, we talk to Zachary Reinert, PhD, Scientific Solution Consultant at Benchling, about how you can…
Broadcast Date: December 12, 2022
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Thanks to cell and gene therapies, diseases considered untreatable a few years ago, now have treatment options that not only manage clinical symptoms but can be curative. The R&D process of such novel therapies, however, involves novel complexities, which require software solutions that are tailored to constantly evolving, cutting-edge approaches. R&D scientists and their IT partners must work together to establish a digital foundation that models their science accurately, provides complete traceability throughout the R&D process, and makes data easily accessible for actionable insights.
In this session of Learning Labs, we talk to Zachary Reinert, PhD, Scientific Solution Consultant at Benchling, about how you can set up your cell and gene therapy R&D for success with data and software strategies aligned with the complexity of these exciting new areas of science. Zach will share representative software solution models and case studies for cell and gene therapy R&D. He’ll discuss the value of using a centralized software solution to help teams establish traceability throughout the R&D process, work in close collaboration, and generate meaningful insights faster. You’ll see a demonstration of solution capabilities specific to cell and gene therapy, including the modeling of different approaches for CAR-T, TCR, and CRISPR, designing plasmids, cell engineering workflows and experiments with structured data capture, and organizing data for quick search and analysis.
All examples will be demonstrated on the Benchling R&D Cloud, a cloud-native platform for biotechnology R&D. In use by over 1000 leading biotech innovators, the R&D Cloud provides a modern experience for R&D scientists with capabilities for biological entity design and registration, experimental data capture, process development and orchestration, inventory, automation, and analysis.
A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelist.
Produced with support from:
The post Cell and Gene Therapy: Unified Digital Solutions for R&D appeared first on GEN – Genetic Engineering and Biotechnology News.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….